This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 Jul;4(1):13-8.

doi: 10.1016/s1535-6108(03)00165-x.

Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?

Ricky W Johnstone¹, Jonathan D Licht

Affiliations

PMID: 12892709
DOI: 10.1016/s1535-6108(03)00165-x

Free article

Review

Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?

Ricky W Johnstone et al. Cancer Cell. 2003 Jul.

Free article

. 2003 Jul;4(1):13-8.

doi: 10.1016/s1535-6108(03)00165-x.

Authors

Ricky W Johnstone¹, Jonathan D Licht

Affiliation

¹ The Peter MacCallum Cancer Centre, East Melbourne 3002, Victoria, Australia.

PMID: 12892709
DOI: 10.1016/s1535-6108(03)00165-x

No abstract available

PubMed Disclaimer

Similar articles

Histone deacetylase inhibitors as new cancer drugs.
Marks PA, Richon VM, Breslow R, Rifkind RA. Marks PA, et al. Curr Opin Oncol. 2001 Nov;13(6):477-83. doi: 10.1097/00001622-200111000-00010. Curr Opin Oncol. 2001. PMID: 11673688 Review.
Histone deacetylase inhibitors, anticancerous mechanism and therapy for gastrointestinal cancers.
Fang JY. Fang JY. J Gastroenterol Hepatol. 2005 Jul;20(7):988-94. doi: 10.1111/j.1440-1746.2005.03807.x. J Gastroenterol Hepatol. 2005. PMID: 15955204 Review.
Histone deacetylase inhibitors: anticancer compounds.
Smith KT, Workman JL. Smith KT, et al. Int J Biochem Cell Biol. 2009 Jan;41(1):21-5. doi: 10.1016/j.biocel.2008.09.008. Epub 2008 Sep 19. Int J Biochem Cell Biol. 2009. PMID: 18845268 Review.
Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond.
Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. Konstantinopoulos PA, et al. Expert Opin Investig Drugs. 2007 May;16(5):569-71. doi: 10.1517/13543784.16.5.569. Expert Opin Investig Drugs. 2007. PMID: 17461732 Review.
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer.
Johnstone RW. Johnstone RW. Nat Rev Drug Discov. 2002 Apr;1(4):287-99. doi: 10.1038/nrd772. Nat Rev Drug Discov. 2002. PMID: 12120280 Review.

See all similar articles

Cited by

Natural HDAC-1/8 inhibitor baicalein exerts therapeutic effect in CBF-AML.
Yu X, Li H, Hu P, Qing Y, Wang X, Zhu M, Wang H, Wang Z, Xu J, Guo Q, Hui H. Yu X, et al. Clin Transl Med. 2020 Aug;10(4):e154. doi: 10.1002/ctm2.154. Clin Transl Med. 2020. PMID: 32898337 Free PMC article.
Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling.
Huang Z, Zhou W, Li Y, Cao M, Wang T, Ma Y, Guo Q, Wang X, Zhang C, Zhang C, Shen W, Liu Y, Chen Y, Zheng J, Yang S, Fan Y, Xiang R. Huang Z, et al. Theranostics. 2018 Oct 5;8(18):4995-5011. doi: 10.7150/thno.26627. eCollection 2018. Theranostics. 2018. PMID: 30429882 Free PMC article.
Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors.
Miller CP, Singh MM, Rivera-Del Valle N, Manton CA, Chandra J. Miller CP, et al. J Biomed Biotechnol. 2011;2011:514261. doi: 10.1155/2011/514261. Epub 2011 Jun 28. J Biomed Biotechnol. 2011. PMID: 21765634 Free PMC article. Review.
A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL.
Hwang JJ, Kim YS, Kim T, Kim MJ, Jeong IG, Lee JH, Choi J, Jang S, Ro S, Kim CS. Hwang JJ, et al. Invest New Drugs. 2012 Aug;30(4):1434-42. doi: 10.1007/s10637-011-9718-1. Epub 2011 Jul 20. Invest New Drugs. 2012. PMID: 21773733
Pre-clinical studies of epigenetic therapies targeting histone modifiers in lung cancer.
Huffman K, Martinez ED. Huffman K, et al. Front Oncol. 2013 Sep 9;3:235. doi: 10.3389/fonc.2013.00235. Front Oncol. 2013. PMID: 24058902 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database